Chocolate Dynamic Vessel Analysis

February 6, 2022 updated by: Querques Giuseppe

Evaluation of the Effects of Chocolate on Anatomy and Functionality of Retinal Blood Vessels

The study aims at evaluating the effect of dark chocolate consumption on anatomy and functionality of retinal blood vessels by comparing these same parameters after milk chocolate consumption.

Study Overview

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Milan, Italy, 20134
        • Giuseppe Querques

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age of 18 years or older
  • Healthy volunteers
  • No vascular diseases
  • No ocular diseases
  • Volunteers capable of understanding informed consent

Exclusion Criteria:

  • Patient unable to follow the instructions
  • Patient unable to come back for follow-up
  • opacity of lens, cornea, or vitreous
  • Allergies that contraindicate pupil dilation
  • Eye diseases
  • Myopia greater than -8.0 Diopter (D),
  • Hyperopia greater than 5.0 D
  • Astigmatism greater than -3.0 D

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: NA
  • Interventional Model: SEQUENTIAL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Main study arm
Patients received intervention 1 and then intervention 2 after 7 weeks
Patients were administered 20 grams of dark chocolate
Patients were administered 7.5 grams of milk chocolate

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Retinal perfusion
Time Frame: Baseline, 2 hours after intervention
Changes in retinal perfusion using Optical Coherence Tomography Angiography
Baseline, 2 hours after intervention
Retinal vascular response
Time Frame: Baseline, 2 hours after intervention
Changes in retinal vascular response to flicker stimulation using Dynamic Vessels Analysis and Retinal Vessels Analysis
Baseline, 2 hours after intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Acuity
Time Frame: Baseline, 2 hours after intervention
Best Corrected Visual Acuity changes
Baseline, 2 hours after intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Francesco Bandello, MD, Ospedale San Raffaele

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

April 9, 2021

Primary Completion (ACTUAL)

July 13, 2021

Study Completion (ACTUAL)

July 13, 2021

Study Registration Dates

First Submitted

January 26, 2022

First Submitted That Met QC Criteria

January 26, 2022

First Posted (ACTUAL)

February 7, 2022

Study Record Updates

Last Update Posted (ACTUAL)

February 23, 2022

Last Update Submitted That Met QC Criteria

February 6, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • FondazioneSanRaffaele

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Retinal Vascular

Clinical Trials on Dark chocolate

3
Subscribe